Keryx gets orphan-drug designation for neuroblastoma treatment Mylan acquires Bioniche Pharma Watson inks deal with Itero Datamonitor: Oral drugs set to dominate MS market by 2014 Pfizer, Samsung Medical Center form liver cancer research partnership Centric Health Resources head to address 5th Annual Rare Disease Leadership Summit Lonza to help manufacture Human Genome Sciences' Benlysta Diplomat Specialty Pharmacy names new VP operations Sprycel receives priority review from FDA Decision Resources: Atrial fibrillation treatments will expand market size to $7 billion First Previous 187 188 189 190 191 Next Last